Novonix (NVX) Common Equity (2020 - 2025)

Novonix (NVX) has 6 years of Common Equity data on file, last reported at $161.7 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity rose 17.5% year-over-year to $161.7 million; the trailing twelve-month figure through Dec 2025 stood at $161.7 million (up 17.5% YoY), and the FY2025 full-year result was $161.7 million, up 17.5% from the prior year.
• Common Equity for Q4 2025 stood at $161.7 million, up from $137.6 million in the prior quarter.
• Across five years, Common Equity topped out at $261.0 million in Q2 2022 and bottomed at $137.6 million in Q4 2024.
• The 5-year median for Common Equity is $172.8 million (2023), against an average of $185.4 million.
• The widest annual swing landed in 2021, when Common Equity surged 218.89%; it then decreased 25.2% in 2024.
• A 5-year view of Common Equity shows it stood at $142.0 million in 2021, then soared by 59.2% to $226.1 million in 2022, then retreated by 18.63% to $183.9 million in 2023, then fell by 25.2% to $137.6 million in 2024, then climbed by 17.5% to $161.7 million in 2025.
• The last three Common Equity figures came in at $161.7 million (Q4 2025), $137.6 million (Q4 2024), and $183.9 million (Q4 2023), per Business Quant data.

Peer Comparison